Interestingly, accessible data from the PanCancer study (TCGA) [5] demonstrated that SF3B1 expression levels were directly associated with neoplasm disease stage, being most expressed in poorly differentiated tumors (Fig. 1F). This evidence concerns the gene SF3B1 and neoplasm.